Project Grant R35GM158434
Award Date
6/1/25
Completion Date
3/31/30
Dollars Obligated
$393K
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This Project Grant award for $444,262 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) supports the development of innovative reagents and methods for synthesizing oligophosphate constructs to enable the exploration of phosphorylated biomolecules and their roles in human physiology, health, and medicine. The award period runs from June 1, 2025 to March 31, 2030 and is being performed by the Massachusetts...
This $300,892 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research to identify and characterize novel dehydrated nonribosomal peptides from Streptomyces bacteria. The research aims to elucidate the biosynthetic pathways and biological roles of these structurally unique natural products, which have potential therapeutic applications. Key activities include genome mining to...
This $401,253 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will support research to elucidate novel cyclic nucleotide signaling pathways and physiological effects in bacteria. The project aims to synthesize chemical tools and use in vitro and in cellulo techniques to investigate the effects of 2',3'-cyclic nucleotide monophosphates (2',3'-cNMPs) on bacterial transcription, translation,...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $387,500.00 to support research focused on understanding the molecular mechanisms that regulate the activity of protein kinases. The principal investigator at The Johns Hopkins University will use the Hippo signaling pathway as a model system to investigate different mechanisms that modulate protein kinase activity. The research...
This federal Project Grant award, valued at $450,313.00, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award supports research to elucidate the molecular mechanisms governing the dynamic remodeling of multidomain enzymatic factories known as nonribosomal peptide synthetases (NRPSs). The project aims to leverage nuclear magnetic resonance (NMR) spectroscopy and computational approaches to...
This $383,746 Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), will support research to characterize the molecular mechanisms and evolution of cyclic diguanylic acid (c-di-GMP) signaling in the antibiotic-producing bacterial genus Streptomyces. The research will focus on three key areas: (1) understanding how c-di-GMP regulates the developmental life cycle in the model species...
This $118,904 federal Project Grant was awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The grant supports research to develop and engineer modular signaling protein domains to gain mechanistic insights into bacterial histidine kinase signal transduction pathways. The research involves using protein design to generate stable sensor and kinase domain variants, with the aim of deconvoluting the...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), aims to delineate the molecular mechanisms by which the protein phosphatase 2A (PP2A) holoenzyme, specifically PP2A/B55α, recognizes its substrates through a new helical motif. The ultimate goal is to use this information to identify direct PP2A/B55α substrates with functions in mitogenic signaling and early cell cycle...
This federal Project Grant award, provided by the National Institute of General Medical Sciences (NIGMS) under CFDA 93.859 Biomedical Research and Research Training Program, supports research to understand the molecular mechanisms that impart plasticity to G protein-coupled receptor (GPCR) and G protein signaling. The $694,875 award will fund research in two areas over a 5-year period beginning February 1, 2025: 1) defining the physiological implications of non-GPCR activation of G protein...
This federal Project Grant award, valued at $455,940.00 and awarded by the U.S. Department of Health and Human Services' National Institute of General Medical Sciences (CFDA 93.859 Biomedical Research and Research Training Program), supports research to investigate the biophysical properties of intrinsically disordered proteins (IDPs) when confined to nanoparticle constructs. The primary objectives are to 1) reveal how nanoparticle binding influences the structural plasticity of IDPs in response...